Citadel Advisors’s Cryo-Cell International CCEL Stock Holding History

Citadel Advisors’s Portfolio CCEL Stock Details CCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,525	Closed	-$50K	–	13077
2025 Q4	$50K	Buy	14,525 +3,127	+27%	+$13K	﹤0.01%	12035
2025 Q3	$52.9K	Sell	11,398 -7,355	-39%	-$34.9K	﹤0.01%	12171
2025 Q2	$97.3K	Buy	18,753 +4,189	+29%	+$22.1K	﹤0.01%	11374
2025 Q1	$92.8K	Buy	+14,564	New	+$106K	﹤0.01%	11580

Other funds holding CCEL

SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's CCEL Position: Q1 2026 in Review

Citadel Advisors sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 14,525 shares — an estimated $50K sold.

Citadel Advisors first reported a position in CCEL in Q1 2025 and held it in 4 quarters. The position peaked at $97.3K in Q2 2025. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

Citadel Advisors reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 14,525 Cryo-Cell International shares in Q1 2026, an estimated $50K.
Citadel Advisors first reported a position in Cryo-Cell International in Q1 2025 and held it in 4 quarters.
Citadel Advisors's Cryo-Cell International position peaked at $97.3K in Q2 2025.
11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.